Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin), the First FDA-Approved Therapy for the Treatment of Long-chain Fatty Acid Oxidation Disorders Fourth U.S. FDA Approval for Ultragenyx in the Past Three Years – All for Rare Diseases which Previously Had No Approved Therapies Ultragenyx to Host Conference Call Today at 4:00 pm [...]

INFORM Conference Explores Future of Disorders of Fatty Acid Oxidation International Network for Fatty Acid Oxidation Research and Management showcased advancements, next-gen researchers Global experts, practitioners, researchers and family members gathered this fall for the ninth meeting of the International Network for Fatty Acid Oxidation Research and Management. Held in [...]

How is CPT2 Diagnosed? Most people never think about the adverse impacts of dieting or skipping a meal on a busy day. We assume that this is a normal function of the body that can be handled by the body. Under normal circumstances, this is true as the body can [...]